Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
- Previous Close
23.82 - Open
24.02 - Bid 23.75 x --
- Ask 23.78 x --
- Day's Range
23.64 - 24.00 - 52 Week Range
18.07 - 26.39 - Volume
1,069,400 - Avg. Volume
2,240,611 - Market Cap (intraday)
12.629B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
22.43 - EPS (TTM)
1.06 - Earnings Date --
- Forward Dividend & Yield 0.48 (2.02%)
- Ex-Dividend Date Jan 24, 2025
- 1y Target Est
--
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. It provides products in the areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
www.cheezheng.com.cnRecent News: 002287.SZ
View MorePerformance Overview: 002287.SZ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002287.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002287.SZ
View MoreValuation Measures
Market Cap
12.63B
Enterprise Value
11.24B
Trailing P/E
22.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.31
Price/Book (mrq)
3.14
Enterprise Value/Revenue
4.73
Enterprise Value/EBITDA
16.56
Financial Highlights
Profitability and Income Statement
Profit Margin
23.31%
Return on Assets (ttm)
6.11%
Return on Equity (ttm)
13.90%
Revenue (ttm)
2.38B
Net Income Avi to Common (ttm)
553.7M
Diluted EPS (ttm)
1.06
Balance Sheet and Cash Flow
Total Cash (mrq)
3.2B
Total Debt/Equity (mrq)
44.45%
Levered Free Cash Flow (ttm)
376.66M